Understanding and treating refractory constipation
- PMID: 24868488
- PMCID: PMC4023327
- DOI: 10.4292/wjgpt.v5.i2.77
Understanding and treating refractory constipation
Abstract
Chronic constipation is a frequently encountered disorder in clinical practice. Most constipated patients benefit from standard medical approaches. However, current therapies may fail in a proportion of patients. These patients deserve better evaluation and thorough investigations before their labeling as refractory to treatment. Indeed, several cases of apparent refractoriness are actually due to misconceptions about constipation, poor basal evaluation (inability to recognize secondary causes of constipation, use of constipating drugs) or inadequate therapeutic regimens. After a careful re-evaluation that takes into account the above factors, a certain percentage of patients can be defined as being actually resistant to first-line medical treatments. These subjects should firstly undergo specific diagnostic examination to ascertain the subtype of constipation. The subsequent therapeutic approach should be then tailored according to their underlying dysfunction. Slow transit patients could benefit from a more robust medical treatment, based on stimulant laxatives (or their combination with osmotic laxatives, particularly over the short-term), enterokinetics (such as prucalopride) or secretagogues (such as lubiprostone or linaclotide). Patients complaining of obstructed defecation are less likely to show a response to medical treatment and might benefit from biofeedback, when available. When all medical treatments prove to be unsatisfactory, other approaches may be attempted in selected patients (sacral neuromodulation, local injection of botulinum toxin, anterograde continence enemas), although with largely unpredictable outcomes. A further although irreversible step is surgery (subtotal colectomy with ileorectal anastomosis or stapled transanal rectal resection), which may confer some benefit to a few patients with refractoriness to medical treatments.
Keywords: Chronic constipation; Laxatives; Medical treatment; Refractory constipation; Surgical treatment.
Similar articles
-
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment).World J Gastroenterol. 2012 Sep 28;18(36):4994-5013. doi: 10.3748/wjg.v18.i36.4994. World J Gastroenterol. 2012. PMID: 23049207 Free PMC article.
-
Constipation: Pathophysiology and Current Therapeutic Approaches.Handb Exp Pharmacol. 2017;239:59-74. doi: 10.1007/164_2016_111. Handb Exp Pharmacol. 2017. PMID: 28185025 Review.
-
Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options.Clin Exp Gastroenterol. 2021 Oct 22;14:413-428. doi: 10.2147/CEG.S256364. eCollection 2021. Clin Exp Gastroenterol. 2021. PMID: 34712055 Free PMC article. Review.
-
Epidemiology and management of chronic constipation in elderly patients.Clin Interv Aging. 2015 Jun 2;10:919-30. doi: 10.2147/CIA.S54304. eCollection 2015. Clin Interv Aging. 2015. PMID: 26082622 Free PMC article. Review.
-
Novel therapies for constipation.World J Gastroenterol. 2013 Dec 7;19(45):8247-51. doi: 10.3748/wjg.v19.i45.8247. World J Gastroenterol. 2013. PMID: 24363515 Free PMC article. Review.
Cited by
-
Lanreotide Autogel in the Treatment of Persistent Diarrhea following a Total Colectomy.Case Rep Gastrointest Med. 2015;2015:686120. doi: 10.1155/2015/686120. Epub 2015 Dec 6. Case Rep Gastrointest Med. 2015. PMID: 26770844 Free PMC article.
-
Exploring Pharmacological Treatments for Chronic Idiopathic Constipation in Adults: A Look Back to the Future.J Clin Med. 2023 Feb 20;12(4):1702. doi: 10.3390/jcm12041702. J Clin Med. 2023. PMID: 36836237 Free PMC article. Review.
-
Comparison of two types of colectomy in treating slow transit constipation with or without melanosis coli.World J Gastroenterol. 2015 Sep 7;21(33):9736-40. doi: 10.3748/wjg.v21.i33.9736. World J Gastroenterol. 2015. PMID: 26361420 Free PMC article.
-
Guanylin, Uroguanylin and Guanylate Cyclase-C Are Expressed in the Gastrointestinal Tract of Horses.Front Physiol. 2019 Sep 27;10:1237. doi: 10.3389/fphys.2019.01237. eCollection 2019. Front Physiol. 2019. PMID: 31611814 Free PMC article.
-
Naringenin induces laxative effects by upregulating the expression levels of c-Kit and SCF, as well as those of aquaporin 3 in mice with loperamide-induced constipation.Int J Mol Med. 2018 Feb;41(2):649-658. doi: 10.3892/ijmm.2017.3301. Epub 2017 Dec 1. Int J Mol Med. 2018. PMID: 29207043 Free PMC article.
References
-
- Bassotti G. Understanding constipation treatment: do we need to strain to obtain better results? Expert Opin Drug Metab Toxicol. 2013;9:387–389. - PubMed
-
- Gaburri M, Bassotti G, Bacci G, Cinti A, Bosso R, Ceccarelli P, Paolocci N, Pelli MA, Morelli A. Functional gut disorders and health care seeking behavior in an Italian non-patient population. Recenti Prog Med. 1989;80:241–244. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources